# Oral Curcumin for Radiation Dermatitis

> **NCT01246973** · PHASE2,PHASE3 · COMPLETED · sponsor: **University of Rochester** · enrollment: 686 (actual)

## Conditions studied

- Radiation-induced Dermatitis

## Interventions

- **DRUG:** Curcumin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01246973
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-11
- **Final completion:** 2015-01
- **Target enrollment:** 686 (ACTUAL)
- **Last updated:** 2016-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01246973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01246973, "Oral Curcumin for Radiation Dermatitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01246973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*